Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old

Manuscript Number: 

22-0440R1

Author(s): 
Gamze Balci Camsari, Bradley F. Boeve, Janisse N. Cabrera-Rodriguez, Julia E. Crook, Gregory S. Day, Dennis W. Dickson, Nilüfer Ertekin-Taner, Neill Graff-Radford, Keith A. Josephs, David S. Knopman, Naomi Kouri, Sydney A. Labuzan, Christian Lachner, John A. Lucas, Michelle M. Mielke, Melissa E. Murray, Ronald C. Petersen, R. Ross Reichard, Habeeba Siddiqui, Aubrey Thompson

Disclosures

Gamze Balci Camsari

  • Nothing to Disclose

Bradley F. Boeve

  • Nothing to Disclose

Janisse N. Cabrera-Rodriguez

  • Nothing to Disclose

Julia E. Crook

  • Nothing to Disclose

Gregory S. Day

  • Consulting Fees:
    Consultant for Parabon Nanolabs Inc, <$2500 Topic Editor (Dementia) for DynaMed (EBSCO), $5-10K Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation (Inc, Canada), uncompensated
    Equity:
    Parabon Nanolabs Inc, stock options Personal stock in ANI Pharmaceuticals
    Lecture Fees:
    PeerView Media Inc Continuing Education Inc
    Patents/Royalties
    Exert Witness for a case of Wernicke encephalopathy (Barrow Law)
    Grants
    • Agency: 
      Horizon
      Dates: 
      4-1-2022, ongoing

Dennis W. Dickson

  • Nothing to Disclose

Nilüfer Ertekin-Taner

  • Nothing to Disclose

Neill Graff-Radford

  • Patents/Royalties
    Wrote a chapter on NPH for UpToDate
    Grants
    • Agency: 
      Esai
      Dates: 
      2022
    • Agency: 
      Biogen
      Dates: 
      2022
    • Agency: 
      Lilly
      Dates: 
      2022

Keith A. Josephs

  • Nothing to Disclose

David S. Knopman

  • Grants
    • Agency: 
      Biogen - clinical trial site
      Dates: 
      2015 to present
    • Agency: 
      Lilly -clinical trial site
      Dates: 
      2013 to present

Naomi Kouri

  • Nothing to Disclose

Sydney A. Labuzan

  • Nothing to Disclose

Christian Lachner

  • Nothing to Disclose

John A. Lucas

  • Nothing to Disclose

Michelle M. Mielke

  • Consulting Fees:
    I have consulted for Biogen, Eli Lilly, LabCorp and Merck

Melissa E. Murray

  • Consulting Fees:
    I served as a paid consultant for AVID Radiopharmaceuticals.

Ronald C. Petersen

  • Consulting Fees:
    Roche, Merck, Genentech, Eisai, Biogen, Nestle
    Patents/Royalties
    Oxford University Press UpToDate

R. Ross Reichard

  • Nothing to Disclose

Habeeba Siddiqui

  • Nothing to Disclose

Aubrey Thompson

  • Nothing to Disclose